Increase in Outpatient Ivermectin Dispensing in the US During the COVID-19 Pandemic: A Cross-Sectional Analysis

J Gen Intern Med. 2021 Sep;36(9):2909-2911. doi: 10.1007/s11606-021-06948-6. Epub 2021 Jun 18.

Authors

Jennifer N Lind¹, Maribeth C Lovegrove², Andrew I Geller², Timothy M Uyeki², S Deblina Datta², Daniel S Budnitz²

Affiliations

¹ COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA. jlind@cdc.gov.
² COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.

No abstract available

Publication types

Letter

MeSH terms

COVID-19 Drug Treatment*
Cross-Sectional Studies
Humans
Ivermectin / administration & dosage*
Outpatients
Pandemics*
United States

Substances

Ivermectin